Related Experiment Video
Updated: May 15, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Immunopathogenesis of chronic obstructive pulmonary disease
Rebecca A Holloway1, Louise E Donnelly
1Airway Diseases, National Heart and Lung Institute, Imperial College London, London, UK.
Current Opinion in Pulmonary Medicine
|January 18, 2013
Summary
Immune cells like macrophages and neutrophils play a complex role in chronic obstructive pulmonary disease (COPD) pathogenesis. Aberrant immune cell function and environmental interactions contribute to persistent inflammation in COPD airways.
Area of Science:
- Immunology
- Pulmonology
- Cell Biology
Background:
- Chronic obstructive pulmonary disease (COPD) is characterized by airflow obstruction and inflammation.
- Cigarette smoke is a primary noxious stimulus driving COPD pathophysiology.
- Immune cell roles in COPD pathogenesis are increasingly recognized.
Purpose of the Study:
- To review the latest advancements in understanding immune cell roles in COPD pathogenesis.
- To discuss the evolving contributions of innate and adaptive immunity in COPD.
Main Methods:
- Literature review of recent studies on immune cells in COPD.
- Analysis of immune cell phenotypes and functions in COPD patients.
- Discussion of environmental influences on immune cell behavior.
Main Results:
- Increased leukocytes (macrophages, neutrophils, lymphocytes) in COPD airways.
- Reduced macrophage phagocytic ability and altered phenotypes in COPD.
- Aberrant neutrophil survival and motility, contributing to tissue destruction.
- Potential roles of Th17 cells and altered lymphocyte subsets in disease progression.
Conclusions:
- COPD pathogenesis involves complex interactions between innate and adaptive immune systems.
- Immune cell dysfunction and environmental factors mediate chronic inflammation in COPD.
- Understanding these cellular mechanisms is crucial for developing new COPD therapies.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...